Cell Senescence and the Genetics of Melanoma Development.
Autor: | Constantinou SM; Molecular & Cellular Sciences Research Section, City St George's, University of London, London, UK., Bennett DC; Molecular & Cellular Sciences Research Section, City St George's, University of London, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2024 Oct; Vol. 63 (10), pp. e23273. |
DOI: | 10.1002/gcc.23273 |
Abstrakt: | Cutaneous malignant melanoma is an aggressive skin cancer with an approximate lifetime risk of 1 in 38 in the UK. While exposure to ultraviolet radiation is a key environmental risk factor for melanoma, up to ~10% of patients report a family history of melanoma, and ~1% have a strong family history. The understanding of causal mutations in melanoma has been critical to the development of novel targeted therapies that have contributed to improved outcomes for late-stage patients. Here, we review current knowledge of the genes affected by familial melanoma mutations and their partial overlap with driver genes commonly mutated in sporadic melanoma development. One theme linking a set of susceptibility loci/genes is the regulation of skin pigmentation and suntanning. The largest functional set of susceptibility variants, typically with high penetrance, includes CDKN2A, RB1, and telomerase reverse transcriptase (TERT) mutations, associated with attenuation of cell senescence. We discuss the mechanisms of action of these gene sets in the biology and progression of nevi and melanoma. (© 2024 The Author(s). Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.) |
Databáze: | MEDLINE |
Externí odkaz: |